AstraZeneca PLC (AZN)
NYSE · Common stock
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow AZN in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on AZN and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
AZN at a glance
Key statistics
$261.82B
Market capitalization
- Previous close
- $168.82
- Open
- $169.04
- Day range
- $168.12 – $169.82
- Volume
- 1.27M
- Average volume (30 sessions)
- 2.96M
- Shares outstanding
- 1.55B
- Price / earnings
- 117.9
- Earnings per share
- $1.43
- Price / book
- 19.4
- Price / sales
- 10.9
- Dividend yield
- 1.35%
- Beta (1 year, vs SPY)
- 0.25
Where the price sits in its year
52-week range
26% of the range
- Below the 52-week high
- -20.7%
- Above the 52-week low
- +10.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day average, below its 200-day
- 20-day average
- $161.76+4.4%
- 50-day average
- $162.32+4.0%
- 200-day average
- $180.78-6.6%
Between the conventional 30 and 70 bands.
+8.3%
1 week
+0.4%
1 month
-0.5%
3 months
-8.2%
Year to date
-0.3%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with AZN
AZN on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on AZN.
See the plans →
Every planScreen names like AZN
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on AZN
Put AZN on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on AZN
See whether there is an open premium alert on AZN, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
AZN headlines
No headlines on the wire for AZN in recent weeks.
SEC Form 4, most recent first
Insider filings
Sharma Mani
+2
See remarks · Grant or award
$319.60 · Oct 6, 2026
Sharma Mani
+20.233
See Remarks · Open-market purchase
$3.25K · Aug 8, 2026
Sharma Mani
+1
See Remarks · Grant or award
$162.60 · Sep 8, 2026
Sharma Mani
+2
SVP, Group Controller · Grant or award
$326.68 · Aug 6, 2026
Sharma Mani
+2
See Remarks · Grant or award
$380.86 · Jul 6, 2026
Sharma Mani
+1
See Remarks · Grant or award
$179.75 · Jun 8, 2026
Sharma Mani
−11.9K
See Remarks · Open-market sale
$2.21M · May 20, 2026
Sharma Mani
+1
See Remarks · Grant or award
$196.03 · Apr 7, 2026
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
- Exchange
- NYSE
- Security
- Common stock
- Employees
- 96,100
- Listed since
- Oct 23, 2009
- Website
- astrazeneca.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.